Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
European Journal of Clinical Pharmacology
|
December 10, 2019
The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)
Sine Donnellan, Daniel F B Wright, Jason A Roberts, et al.
Clinical Pharmacokinetics
|
December 18, 2024
Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation Study
Melanie White-Koning, Daniel F B Wright, Dyfrig A Hughes, et al.
Plos One
|
February 18, 2021
Metformin doses to ensure efficacy and safety in patients with reduced kidney function
Isabelle H S Kuan, Luke C Wilson, Jed C Leishman, et al.
British Journal of Clinical Pharmacology
|
May 18, 2021
Does the intact nephron hypothesis provide a reasonable model for metformin dosing in chronic kidney disease?
Sudeep Pradhan, Stephen B Duffull, Luke C Wilson, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
May 14, 2024
The experiences and perspectives of people with gout on urate self-monitoring
Toni J F Michael, Jian S Chan, Stephen Hughes, et al.
Drugs in R&D
|
May 7, 2014
Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C
Paul K L Chin, Daniel F B Wright, Mei Zhang, et al.
British Journal of Clinical Pharmacology
|
February 15, 2024
The development and evaluation of dose-prediction tools for allopurinol therapy (Easy-Allo tools)
Daniel F B Wright, Hailemichael Z Hishe, Sophie L Stocker, et al.
Joint Bone Spine
|
August 13, 2013
Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone
Rebecca L Roberts, Mary C Wallace, Daniel F B Wright, et al.
Studies in Health Technology and Informatics
|
April 22, 2009
Genotypic Approaches to Therapy in Children (GATC): using information technology to improve drug safety
E Wong, B C Carleton, D F B Wright, et al.
British Journal of Clinical Pharmacology
|
April 19, 2017
Individualising the dose of allopurinol in patients with gout
Diluk R W Kannangara, Garry G Graham, Daniel F B Wright, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
European Journal of Clinical Pharmacology
|
December 10, 2019
The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)
Sine Donnellan, Daniel F B Wright, Jason A Roberts, et al.
Clinical Pharmacokinetics
|
December 18, 2024
Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation Study
Melanie White-Koning, Daniel F B Wright, Dyfrig A Hughes, et al.
Plos One
|
February 18, 2021
Metformin doses to ensure efficacy and safety in patients with reduced kidney function
Isabelle H S Kuan, Luke C Wilson, Jed C Leishman, et al.
British Journal of Clinical Pharmacology
|
May 18, 2021
Does the intact nephron hypothesis provide a reasonable model for metformin dosing in chronic kidney disease?
Sudeep Pradhan, Stephen B Duffull, Luke C Wilson, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
May 14, 2024
The experiences and perspectives of people with gout on urate self-monitoring
Toni J F Michael, Jian S Chan, Stephen Hughes, et al.
Drugs in R&D
|
May 7, 2014
Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C
Paul K L Chin, Daniel F B Wright, Mei Zhang, et al.
British Journal of Clinical Pharmacology
|
February 15, 2024
The development and evaluation of dose-prediction tools for allopurinol therapy (Easy-Allo tools)
Daniel F B Wright, Hailemichael Z Hishe, Sophie L Stocker, et al.
Joint Bone Spine
|
August 13, 2013
Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone
Rebecca L Roberts, Mary C Wallace, Daniel F B Wright, et al.
Studies in Health Technology and Informatics
|
April 22, 2009
Genotypic Approaches to Therapy in Children (GATC): using information technology to improve drug safety
E Wong, B C Carleton, D F B Wright, et al.
British Journal of Clinical Pharmacology
|
April 19, 2017
Individualising the dose of allopurinol in patients with gout
Diluk R W Kannangara, Garry G Graham, Daniel F B Wright, et al.
Page
of 9